Sunday, May 14, 2023 11:15 AM – 12:00 PM ET Exhibit Hall D, Room 2
Exhibitor Workshop: Cellecta, Inc.
TCR and BCR Repertoire Analysis and Other Approaches for the Discovery of Drug Targets, Resistance Mechanisms, and Biomarkers
- Paul Diehl, Ph.D., Chief Operating Officer, Flexible and Scalable Genetic Screens for Discovery and Characterization of Novel Therapeutic Targets
- Alex Chenchik, Ph.D., President & Chief Scientific Officer, Improved Adaptive Immune Receptor Repertoire
We will introduce a number of Cellecta technologies along with relevant data for drug and biomarker discovery and validation, including CRISPR functional screening and cell tracking tools. Also introduced will be the recently -launched DriverMap™ Adaptive Immune Receptor (AIR) Profiling Assay that enables the identification of more clonotypes and their activation levels with great sensitivity and reproducibility.